The effects of piroxicam to the muscosal barrier of the bladder after overdistension - An experimental study in rabbits

International Urology and Nephrology

Volumn 34, Issue 3, 2002, Pages 321-324

  Barlas, Meral ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Bladder; Inflammation; Overdistension; Permeability; Proxicam

Indexed keywords

FUROSEMIDE; ISOTONIC SOLUTION; KETAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOBARBITAL; PIROXICAM; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; TRYPAN BLUE; XYLAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER BIOPSY; BLADDER CATHETERIZATION; BLADDER DISTENSION; BLADDER MUCOSA; BLADDER NECK; BLADDER NECK STENOSIS; BLADDER WALL; CONTROLLED STUDY; CYSTITIS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG OVERDOSE; INFUSION; MALE; NONHUMAN; PERITONEAL CAVITY; PERMEABILITY BARRIER; RABBIT; SAMPLING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DISEASE MODELS, ANIMAL; INFLAMMATION; MALE; MUCOUS MEMBRANE; PIROXICAM; RABBITS; URINARY BLADDER; URINARY BLADDER NECK OBSTRUCTION;

EID: 0041312670     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1024449702272     Document Type: Article

References (16)

1. Dunn M, Smith JC, Ardran GM. Prolonged bladder distension as a treatment of urgency and urge incontinence of urine. Br J Urol 1974; 46: 645.
2. Hurst RE, Rhodes SW, Adamson PB et al. Functional and structural characteristics of the glycosaminoglycans of the bladder luminal surface. J Urol 1987; 138: 433.
3. Leppilahti M, Kallioinen M, Tammela TL. Duration of increased mucosal permeability of the urinary bladder after acute overdistension: An experimental study in rats. Urol Res 1999; 27: 272.
4. Parsons CL, Lilly JD, Stein P. Epithelial dysfunction in non-bacterial cystitis (interstitial cystitis). J Urol 1991; 145: 732.
5. Parson CL, Greebspan C et al. Role of surface mucin in primary antibacterial defence of the bladder. J Urology 1977; 9: 48.
6. Kato K, Wein AJ, Kitada S et al. The functional effect of mild outlet obstruction on the rabbit urinary bladder. J Urol 1988; 140: 880.
7. Monson FC, Wein AJ, McKenna BA et al. Indigo carmine as a quantitative indicator of urothelian integrity. J of Urol 1991; 145: 842.
8. Pengelly AW, Stephenson T, Milroy EJ et al. Results of prolonged bladder distension as treatment for detrusor instability. Br J Urol 1978; 50: 243.
9. Dunn M, Ramsen J. Interstital cystitis, treated by prolonged bladder distension. Br J Urol 1977; 49: 641.
10. Koff SA. Non-Neuropathic Vesicourthral Dysfunction in Children. Oxford: Reed Educational and Professional Publishing Ltd., 1997.
11. Ramsden PD, Smith JC, Dunn M, Ardran GM. Distension therapy for the unstable bladder: Later results including an assessment of distension. Br J Urol 1976; 48: 623.
12. Payan D, Katzung BG. Non-Steroidal Anti-Inflammatory Drugs; Nonopioid Analgesics; Drugs Used in Gout. Connecticut: Appleton and Lange, Van Zang Streets Norwalk, 1995.
13. Lasanen L. Combined trypan blue and glyoxylic acid-induced catecholamine fluorescence in the female rat urinary bladder after distension. Scand J Urol Nephrol 1993; 27: 175.
14. Tammel TLJ, Levin RM. The influence of acute overdistension on rat bladder function and DNA synthesis. J Urol 1993; 150: 1533.
15. Tong YC, Monson FC, Erika B, Levin RM. Effects of acute in vitro over distension of the rabbit urinary bladder on DNA synthesis. J Urol 1992; 148: 1347.
16. Michael R, Ruggieri PM. Heparin inhibition of increased bacterial adherence following overdistension, ischemia and partial outlet obstruction of the rabbit urinary bladder. J Urol 1986; 136: 132.